These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 24829417)

  • 1. IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin.
    Foster AM; Baliwag J; Chen CS; Guzman AM; Stoll SW; Gudjonsson JE; Ward NL; Johnston A
    J Immunol; 2014 Jun; 192(12):6053-61. PubMed ID: 24829417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
    Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
    Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-36R ligands are potent regulators of dendritic and T cells.
    Vigne S; Palmer G; Lamacchia C; Martin P; Talabot-Ayer D; Rodriguez E; Ronchi F; Sallusto F; Dinh H; Sims JE; Gabay C
    Blood; 2011 Nov; 118(22):5813-23. PubMed ID: 21860022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-36α is involved in hapten-specific T-cell induction, but not local inflammation, during contact hypersensitivity.
    Numata T; Yoshizaki T; Yamaguchi S; Shimura E; Iwakura Y; Harada K; Sudo K; Tsuboi R; Nakae S
    Biochem Biophys Res Commun; 2018 Nov; 506(3):429-436. PubMed ID: 30352688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology of IL-36 cytokines and their role in disease.
    Gresnigt MS; van de Veerdonk FL
    Semin Immunol; 2013 Dec; 25(6):458-65. PubMed ID: 24355486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanized mouse model of skin inflammation is characterized by disturbed keratinocyte differentiation and influx of IL-17A producing T cells.
    de Oliveira VL; Keijsers RR; van de Kerkhof PC; Seyger MM; Fasse E; Svensson L; Latta M; Norsgaard H; Labuda T; Hupkens P; van Erp PE; Joosten I; Koenen HJ
    PLoS One; 2012; 7(10):e45509. PubMed ID: 23094018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk.
    Tortola L; Rosenwald E; Abel B; Blumberg H; Schäfer M; Coyle AJ; Renauld JC; Werner S; Kisielow J; Kopf M
    J Clin Invest; 2012 Nov; 122(11):3965-76. PubMed ID: 23064362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of phospholipase Cε in keratinocytes upregulates cytokine expression and causes dermatitis with acanthosis and T-cell infiltration.
    Takenaka N; Edamatsu H; Suzuki N; Saito H; Inoue Y; Oka M; Hu L; Kataoka T
    Eur J Immunol; 2011 Jan; 41(1):202-13. PubMed ID: 21182091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-36α exerts pro-inflammatory effects in the lungs of mice.
    Ramadas RA; Ewart SL; Iwakura Y; Medoff BD; LeVine AM
    PLoS One; 2012; 7(9):e45784. PubMed ID: 23029241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression.
    Johnston A; Xing X; Guzman AM; Riblett M; Loyd CM; Ward NL; Wohn C; Prens EP; Wang F; Maier LE; Kang S; Voorhees JJ; Elder JT; Gudjonsson JE
    J Immunol; 2011 Feb; 186(4):2613-22. PubMed ID: 21242515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.
    Towne JE; Renshaw BR; Douangpanya J; Lipsky BP; Shen M; Gabel CA; Sims JE
    J Biol Chem; 2011 Dec; 286(49):42594-42602. PubMed ID: 21965679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.
    Su Z; Paulsboe S; Wetter J; Salte K; Kannan A; Mathew S; Horowitz A; Gerstein C; Namovic M; Todorović V; Seagal J; Edelmayer RM; Viner M; Rinaldi L; Zhou L; Leys L; Huang S; Wang L; Sadhukhan R; Honore P; McGaraughty S; Scott VE
    Exp Dermatol; 2019 Feb; 28(2):113-120. PubMed ID: 30417427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines.
    Dietrich D; Martin P; Flacher V; Sun Y; Jarrossay D; Brembilla N; Mueller C; Arnett HA; Palmer G; Towne J; Gabay C
    Cytokine; 2016 Aug; 84():88-98. PubMed ID: 27259168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop.
    Hashiguchi Y; Yabe R; Chung SH; Murayama MA; Yoshida K; Matsuo K; Kubo S; Saijo S; Nakamura Y; Matsue H; Iwakura Y
    J Immunol; 2018 Jul; 201(1):167-182. PubMed ID: 29794016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines.
    Albanesi C; Scarponi C; Sebastiani S; Cavani A; Federici M; De Pità O; Puddu P; Girolomoni G
    J Immunol; 2000 Aug; 165(3):1395-402. PubMed ID: 10903743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand.
    Wesa A; Galy A
    BMC Immunol; 2002 Oct; 3():14. PubMed ID: 12385649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD8+ T cells.
    Günther C; Carballido-Perrig N; Kaesler S; Carballido JM; Biedermann T
    J Invest Dermatol; 2012 Mar; 132(3 Pt 1):626-34. PubMed ID: 22113484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9.
    Mutamba S; Allison A; Mahida Y; Barrow P; Foster N
    Eur J Immunol; 2012 Mar; 42(3):607-17. PubMed ID: 22144259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus Epicutaneous Exposure Drives Skin Inflammation via IL-36-Mediated T Cell Responses.
    Liu H; Archer NK; Dillen CA; Wang Y; Ashbaugh AG; Ortines RV; Kao T; Lee SK; Cai SS; Miller RJ; Marchitto MC; Zhang E; Riggins DP; Plaut RD; Stibitz S; Geha RS; Miller LS
    Cell Host Microbe; 2017 Nov; 22(5):653-666.e5. PubMed ID: 29120743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1.
    Milora KA; Fu H; Dubaz O; Jensen LE
    J Invest Dermatol; 2015 Dec; 135(12):2992-3000. PubMed ID: 26203636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.